RU2283105C2 - Аналоги жирных кислот для лечения рака - Google Patents

Аналоги жирных кислот для лечения рака Download PDF

Info

Publication number
RU2283105C2
RU2283105C2 RU2002134754/15A RU2002134754A RU2283105C2 RU 2283105 C2 RU2283105 C2 RU 2283105C2 RU 2002134754/15 A RU2002134754/15 A RU 2002134754/15A RU 2002134754 A RU2002134754 A RU 2002134754A RU 2283105 C2 RU2283105 C2 RU 2283105C2
Authority
RU
Russia
Prior art keywords
alkyl
tumor
compound
fatty acid
inhibiting
Prior art date
Application number
RU2002134754/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2002134754A (ru
Inventor
Рольф БЕРГЕ (NO)
Рольф БЕРГЕ
Original Assignee
Тиа Медика Ас
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тиа Медика Ас filed Critical Тиа Медика Ас
Publication of RU2002134754A publication Critical patent/RU2002134754A/ru
Application granted granted Critical
Publication of RU2283105C2 publication Critical patent/RU2283105C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RU2002134754/15A 2000-07-13 2001-07-13 Аналоги жирных кислот для лечения рака RU2283105C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20003591A NO20003591L (no) 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft
NO20003591 2000-07-13

Publications (2)

Publication Number Publication Date
RU2002134754A RU2002134754A (ru) 2004-07-20
RU2283105C2 true RU2283105C2 (ru) 2006-09-10

Family

ID=19911376

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002134754/15A RU2283105C2 (ru) 2000-07-13 2001-07-13 Аналоги жирных кислот для лечения рака

Country Status (17)

Country Link
US (1) US7378443B2 (enExample)
EP (1) EP1313463B1 (enExample)
JP (1) JP2004502732A (enExample)
KR (2) KR100861428B1 (enExample)
CN (1) CN100569228C (enExample)
AT (1) ATE320802T1 (enExample)
AU (2) AU7286001A (enExample)
BR (1) BR0112399A (enExample)
CA (1) CA2414480A1 (enExample)
DE (1) DE60118198T2 (enExample)
ES (1) ES2261441T3 (enExample)
MX (1) MXPA02012944A (enExample)
NO (2) NO20003591L (enExample)
NZ (1) NZ523316A (enExample)
RU (1) RU2283105C2 (enExample)
WO (1) WO2002003983A1 (enExample)
ZA (1) ZA200210028B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
AU2003278602C1 (en) 2002-06-20 2010-08-12 Pronova Biopharma Norge As Sulfur-containing phospholipid derivatives
JP2008506773A (ja) 2004-07-19 2008-03-06 ティア メディカ アクスイェ セルスカプ タンパク質材料と非酸化性脂肪酸体を含む組成物
NO20053519L (no) * 2005-07-18 2007-01-19 Thia Medica As Anvendelse av forbindelser som omfatter fettsyrer
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
EP2334234A4 (en) 2008-09-19 2013-03-20 Tandem Diabetes Care Inc DEVICE FOR MEASURING THE CONCENTRATION OF A SOLVED SUBSTANCE AND CORRESPONDING METHOD
US8758323B2 (en) 2009-07-30 2014-06-24 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
AU2014228387B2 (en) 2013-03-11 2016-09-01 Sciadonics, Inc. Lipid compositions containing bioactive fatty acids
WO2014140934A2 (en) 2013-03-11 2014-09-18 Life Science Nutrition As Natural lipids containing non-oxidizable fatty acids
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
DE102014116958B9 (de) * 2014-11-19 2017-10-05 Trumpf Laser- Und Systemtechnik Gmbh Optisches System zur Strahlformung eines Laserstrahls, Laserbearbeitungsanlage, Verfahren zur Materialbearbeitung und Verwenden einer gemeinsamen langgezogenen Fokuszone zur Lasermaterialbearbeitung
KR20180027516A (ko) * 2015-06-11 2018-03-14 유니버시티 오브 마이애미 암 치료 및 진단
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用
CN107235880B (zh) * 2017-06-30 2018-10-30 江南大学 一种含硒阳离子表面活性剂及其应用
GB201910644D0 (en) * 2019-07-25 2019-09-11 Coegin Pharma As Cancer Treatment
AU2020405068A1 (en) 2019-12-18 2022-07-07 Stinginn Llc Substituted 1,2, 4-triazoles and methods of use
US11897888B1 (en) 2020-04-30 2024-02-13 Stinginn Llc Small molecular inhibitors of sting signaling compositions and methods of use
CN115260964A (zh) * 2022-08-29 2022-11-01 烟台市福山义昌精细化工厂 一种石油油管丝扣专用密封胶及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997003663A1 (en) * 1995-07-14 1997-02-06 Rolf Berge NON-β-OXIDIZABLE FATTY ACID ANALOGUES, THEIR USES AS THERAPEUTIC ACTIVE MEDICAMENTS, AND PREPARATION THEREOF
WO1998025598A2 (en) * 1996-12-11 1998-06-18 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumour cell growth
WO1998030573A1 (de) * 1997-01-13 1998-07-16 Glycorex Ab Antiadhäsive sulfatid-mimetika
RU2135468C1 (ru) * 1991-11-29 1999-08-27 Актиеболагет Астра Органические соли n,n'-диацетилцистина, способы их получения, фармацевтическая композиция, способ лечения

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686377B2 (ja) * 1985-09-30 1994-11-02 日清製粉株式会社 がん転移抑制剤
JPH0797320A (ja) * 1993-08-04 1995-04-11 Takuma Sasaki 制癌剤
US6358915B1 (en) * 1995-03-07 2002-03-19 George Washington University Methods for inhibiting metastasis
AU693682B2 (en) * 1995-04-10 1998-07-02 Taiho Pharmaceutical Co., Ltd. Cancerous metastasis inhibitor
WO1999058120A1 (en) * 1998-05-08 1999-11-18 Rolf Berge USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
JP4993878B2 (ja) * 2005-06-28 2012-08-08 ダイキョーニシカワ株式会社 多気筒エンジンの吸気装置

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2135468C1 (ru) * 1991-11-29 1999-08-27 Актиеболагет Астра Органические соли n,n'-диацетилцистина, способы их получения, фармацевтическая композиция, способ лечения
WO1997003663A1 (en) * 1995-07-14 1997-02-06 Rolf Berge NON-β-OXIDIZABLE FATTY ACID ANALOGUES, THEIR USES AS THERAPEUTIC ACTIVE MEDICAMENTS, AND PREPARATION THEREOF
WO1998025598A2 (en) * 1996-12-11 1998-06-18 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumour cell growth
WO1998030573A1 (de) * 1997-01-13 1998-07-16 Glycorex Ab Antiadhäsive sulfatid-mimetika

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Р.С.Сатоскар, Бандаркар С.Д. Фармакология и фармакотерапия. М.: Медицина, 1986, т.1, с.57. *
реферат из Entrez PubMed: Raspe E. et al. Modulation of the tar liver apolipoprotein gene expression and serum lipid levels by tetradecyl-thioacetic acid (TTA) via PPARalpha activation. J Lipid Res. 1999 Nov; 40(11):2099-110. *

Also Published As

Publication number Publication date
NZ523316A (en) 2004-09-24
ATE320802T1 (de) 2006-04-15
DE60118198T2 (de) 2007-01-25
BR0112399A (pt) 2003-05-27
KR20030016399A (ko) 2003-02-26
NO324634B1 (no) 2007-11-26
WO2002003983A1 (en) 2002-01-17
US7378443B2 (en) 2008-05-27
CN1441671A (zh) 2003-09-10
JP2004502732A (ja) 2004-01-29
ZA200210028B (en) 2004-01-26
MXPA02012944A (es) 2004-05-17
NO20003591L (no) 2002-01-14
US20040024063A1 (en) 2004-02-05
AU7286001A (en) 2002-01-21
CA2414480A1 (en) 2002-01-17
DE60118198D1 (de) 2006-05-11
ES2261441T3 (es) 2006-11-16
CN100569228C (zh) 2009-12-16
KR100861428B1 (ko) 2008-10-02
NO20025930L (no) 2003-01-13
AU2001272860B2 (en) 2005-11-24
NO20003591D0 (no) 2000-07-13
NO20025930D0 (no) 2002-12-11
EP1313463A1 (en) 2003-05-28
KR20080071598A (ko) 2008-08-04
HK1057473A1 (zh) 2004-04-08
EP1313463B1 (en) 2006-03-22

Similar Documents

Publication Publication Date Title
AU2001272860B2 (en) Fatty acid analogues for the treatment of cancer
AU2001272860A1 (en) Fatty acid analogues for the treatment of cancer
US5925669A (en) Carrier compositions for anti-neoplastic drugs
US20020037917A1 (en) Treatment of cancer using lipoic acid in combination with ascorbic acid
PT706373E (pt) Taxol encapsulado num liposoma e um metodo
AU2016298175B2 (en) Compositions and methods of treating cancer
ZA200308763B (en) Methods for inhibiting angiogenesis.
JPH0225415A (ja) 癌転移抑制剤
US8278349B2 (en) Cancer treatment using FTS and 2-deoxyglucose
US9987301B2 (en) Heparin-based compositions and methods for the inhibition of metastasis
TW202114716A (zh) 含有對硼苯基丙胺酸之注射液劑之防止析出方法
JP2004536857A (ja) 癌の治療のための方法及び組成物
HK1057473B (en) Fatty acid analogues for the treatment of cancer
US5681857A (en) Alkaline salt solutions for treating cancerous tumors
US20040048807A1 (en) Angiogenesis inhibitors
EP2056839A1 (en) Combination approaches to cancer treatment
JPH10330261A (ja) ガン治療用薬剤
US20040254123A1 (en) Malignant cell differentiation inducer compositions and utilization of the same
JP2000136132A (ja) 癌転移抑制剤

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20100714